Cellectar Biosciences, Inc. (NASDAQ:CLRB) Short Interest Up 12.1% in November

Cellectar Biosciences, Inc. (NASDAQ:CLRB – Get Free Report) was the recipient of a significant growth in short interest in November. As of November 30th, there was short interest totalling 1,300,000 shares, a growth of 12.1% from the November 15th total of 1,160,000 shares. Currently, 3.3% of the shares of the stock are short sold. Based […]

Leave a Reply

Your email address will not be published.

Previous post Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Short Interest Update
Next post Flughafen Wien Aktiengesellschaft (OTCMKTS:VIAAY) Reaches New 1-Year Low – Should You Sell?